Trusted Messenger Intervention

Dartmouth-Hitchcock Medical Center2 enrolled

Overview

The objective of this pilot study is to develop and evaluate test a trusted messenger intervention targeting vaccine hesitancy in patients on an inpatient psychiatric hospital setting with both acute and chronic patients.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

Conditions

Vaccine Hesitancy

Interventions

Trusted MessengerBEHAVIORAL

A nested waitlist design in which patients and staff are nested within two inpatient psychiatric units. New Hampshire Hospital staff will be trained to deliver the trusted messenger intervention up to 24 patients on the first unit while the second unit receives care as usual, during which time in-house vaccinations among patients on both units will be tracked in a registry. After a 3-week study period, up to 24 patients on the second unit will receive the trusted messenger intervention and followed for a period of 3 weeks. The trusted messenger intervention will consist of staff who are trained to engage patients informally and assist building social norms for vaccine uptake supported by weekly and as-needed check-ins with a content expert who can answer specific vaccine related questions over a 3 week period.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Able and willing to give verbal informed consent to participate in the study or able to assent with guardian consent * Expected to remain in the hospital for the duration of the study * Mental health diagnosis Demographics * Male, female, or transgender (no exclusion criteria based on gender or sexual orientation) * Ages 18 or older * Any race or ethnicity * English speaking Exclusion Criteria: * Cognitive impairment sufficient to interfere with participant's ability to provide assent * People who are non-English speakers or who have major visual or hearing impairment will be excluded given the need to converse with the Trusted Messenger verbally * People who have received any of the available forms of the COVID-19 vaccine, or those with a medical exemption for receiving the vaccine.

Locations (1)

New Hampshire Hospital

Concord, New Hampshire, United States

Outcomes

Primary Outcomes

Vaccine acceptance- This will be measured using the COVID Vaccine Hesitancy Questionnaire

The participant is willing to receive the COVID-19 vaccine

Time frame: Participant is willing to receive the vaccine by the end of week 6 of participation from baseline.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.